🔎 Trials Near Me

Home › Atherosclerosis › Nebraska

Pag-aaral pangklinika para sa Atherosclerosis sa Nebraska

7 pag-aaral para sa Atherosclerosis ang naghahanap ng mga kalahok sa mga site sa Nebraska.

Mga Lungsod sa Nebraska

Opisyal na teksto ng pag-aaral (English)

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • Bryan Heart, Lincoln
  • University of Nebraska Medical Center, Omaha
  • Primary Clinical Research, Papillion
Nagre-recruitPhase 3
Edad 45 hanggang 99 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07037433

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  • GSR Enterprises, Inc., Lincoln
  • Great Plains Health - Nephrology, North Platte
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05485961

Detecting Peripheral Artery Disease With the Pulse

  • University of Nebraska at Omaha Health Science Collaborative, Omaha
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 19 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07226193

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

  • Research Site, Elkhorn
  • Research Site, Fremont
  • Research Site, Omaha
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT07000357

Oxygen-guided Supervised Exercise Therapy

  • Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, Omaha
Nagre-recruit
Lahat ng edad · Lahat ng kasarian · Na-update Ene 13, 2026 · NCT06003855

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

  • Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, Omaha
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 17, 2025 · NCT02915198

Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.